Hapoalim Securities Reiterates a 'Buy' on Protalix (PLX); Raises PT in Wake of Pfizer (PFE) Deal
Tweet Send to a Friend
Hapoalim Securities raises price target from $10 to $12 on Protalix (NYSE: PLX), reiterates a 'Buy' rating.
Hapoalim analyst says, "Yesterday ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Hapoalim analyst says, "Yesterday ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
